Chase AIPricingFAQs
Display currency
Loading news…

Morria Biopharmaceuticals

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
London, England, United Kingdom Founded 2005 1-10 employees For Profit

Morria Biopharmaceuticals engages in the discovery and development of multi-functional anti-inflammatory drugs.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0
Ticker
MRRBY
OTCQB
Patents
2

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
MRRBY
Exchange
OTCQB
IPO date
Feb 19, 2013

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
6
Active products
11
Patents granted
2
Trademarks
0
Top patent class
a61
IT spend
$110K

Company Info

Founded
2005
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
HQ
London, England, United Kingdom
Region
Europe, Middle East, and Africa (EMEA)
Exit date
Feb 19, 2013

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
1.7
Trend (90d)
1.6

Key People at Morria Biopharmaceuticals

Chief Medical Officer

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Morria Biopharmaceuticals

Loading news…

FAQs about Morria Biopharmaceuticals

People who checked this page also checked these

Browse the full Acquirezy directory.
Morria Biopharmaceuticals - Company Profile, Full Acquisitions List, Funding and Investments